Orchestra BioMed (OBIO) News Today $3.09 -0.08 (-2.52%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$3.11 +0.02 (+0.65%) As of 07/18/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OBIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Analysts Set Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Price Target at $14.20July 15, 2025 | americanbankingnews.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Buy" by BrokeragesJuly 12, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% - Here's What HappenedJuly 10, 2025 | marketbeat.comHedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year lossesJuly 2, 2025 | finance.yahoo.comOrchestra BioMed Confirms Director Elections and AuditorJune 24, 2025 | tipranks.comOrchestra BioMed Highlights Potential of AVIM Therapy for Managing Hypertension in High-Risk Patients at CSI 2025 MeetingJune 20, 2025 | nasdaq.comOrchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 MeetingJune 18, 2025 | msn.comOrchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025June 18, 2025 | globenewswire.comOrchestra BioMed: Two Best-In-Class Devices And Promising PartnershipsMay 28, 2025 | seekingalpha.comOrchestra BioMed (NASDAQ:OBIO) Announces Quarterly Earnings ResultsMay 14, 2025 | marketbeat.comOrchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative OptimismMay 14, 2025 | seekingalpha.comOrchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical MilestonesMay 12, 2025 | globenewswire.comOrchestra BioMed Expands Patent Portfolio for AVIM Therapy, Gains FDA Breakthrough DesignationMay 11, 2025 | msn.comOrchestra BioMed Expands Patent Portfolio with 10 New Patents for Hypertension Treatment, Totaling 120 Global PatentsMay 9, 2025 | nasdaq.comOrchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart FailureMay 8, 2025 | finance.yahoo.comBarclays Has Lowered Expectations for Orchestra BioMed (NASDAQ:OBIO) Stock PriceMay 7, 2025 | marketbeat.comOrchestra BioMed's AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart FailureMay 7, 2025 | globenewswire.comBoxer Capital Management LLC Makes New $953,000 Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)May 4, 2025 | marketbeat.comOrchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR TreatmentMay 1, 2025 | msn.comOrchestra BioMed to Present at Jefferies Global Healthcare ConferenceMay 1, 2025 | msn.comFDA approves head-to-head trial of Orchestra BioMed’s balloonApril 30, 2025 | investing.comOrchestra BioMed (NASDAQ:OBIO) Shares Down 6.1% - Time to Sell?April 30, 2025 | marketbeat.comOrchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated BalloonApril 29, 2025 | globenewswire.comOrchestra BioMed to Participate in Upcoming Institutional Investor ConferencesApril 28, 2025 | globenewswire.comOrchestra BioMed (NASDAQ:OBIO) Given Buy Rating at Chardan CapitalApril 24, 2025 | marketbeat.comOrchestra BioMed to Highlight Advancements in Cardiac Therapy at HRS 2025April 24, 2025 | msn.comOrchestra BioMed announces AVIM therapy-focused satellite symposium at HRS 2025April 23, 2025 | markets.businessinsider.comOrchestra BioMed granted breakthrough device designation, says H.C. WainwrightApril 23, 2025 | markets.businessinsider.comOrchestra BioMed Secures FDA Breakthrough Device Designation for AVIM TherapyApril 23, 2025 | msn.comOrchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual MeetingApril 23, 2025 | globenewswire.comOrchestra BioMed shares surge on FDA breakthrough designationApril 22, 2025 | in.investing.comOrchestra BioMed Receives FDA Breakthrough Device Designation for AVIM TherapyApril 22, 2025 | globenewswire.comWhat is B. Riley's Estimate for OBIO Q1 Earnings?April 8, 2025 | marketbeat.comChardan Capital Has Strong Outlook for OBIO FY2025 EarningsApril 8, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Upgraded by B. Riley to "Strong-Buy" RatingApril 7, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Given New $12.00 Price Target at HC WainwrightApril 6, 2025 | marketbeat.comOrchestra BioMed price target lowered to $12 from $14 at H.C. WainwrightApril 5, 2025 | markets.businessinsider.com4OBIO : Where Orchestra BioMed Hldgs Stands With AnalystsApril 4, 2025 | benzinga.comOrchestra BioMed's (OBIO) Buy Rating Reiterated at Chardan CapitalApril 4, 2025 | marketbeat.comOrchestra BioMed Reports 2024 Financial Results and Advances Cardiovascular TherapyApril 2, 2025 | msn.comOrchestra BioMed (NASDAQ:OBIO) Posts Earnings Results, Hits EstimatesApril 1, 2025 | marketbeat.comOrchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business UpdateMarch 31, 2025 | globenewswire.comOrchestra BioMed initiated with a Buy at BTIGMarch 21, 2025 | markets.businessinsider.comBTIG Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy RecommendationMarch 21, 2025 | msn.comOrchestra BioMed (NASDAQ:OBIO) Coverage Initiated at BTIG ResearchMarch 21, 2025 | marketbeat.comOrchestra BioMed (OBIO) Projected to Post Earnings on WednesdayMarch 19, 2025 | marketbeat.comOrchestra BioMed's (OBIO) Buy Rating Reiterated at HC WainwrightMarch 10, 2025 | marketbeat.comOrchestra BioMed (NASDAQ:OBIO) Stock Price Up 3.4% - Still a Buy?March 8, 2025 | marketbeat.comOrchestra BioMed to Present at Upcoming Investor ConferencesFebruary 20, 2025 | globenewswire.comOrchestra names Vivek Reddy as chairman of BACKBEAT study steering committeeFebruary 18, 2025 | markets.businessinsider.com Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address OBIO Media Mentions By Week OBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OBIO News Sentiment▼0.760.57▲Average Medical News Sentiment OBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OBIO Articles This Week▼12▲OBIO Articles Average Week Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BFLY News Today DCTH News Today TMCI News Today OM News Today CLPT News Today RXST News Today NPCE News Today SNWV News Today NNOX News Today CATX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OBIO) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBIO Stock Alerts